Skip to main navigation Skip to search Skip to main content

Safety and immunogenicity of a novel Rift Valley fever candidate vaccine, RVax-1

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date03/10/20 → 02/28/22

Funding

  • National Institute of Allergy & Infectious Disease: $87,865.00